DJIA 17,812.19 19.51 0.11%
NASDAQ 5,102.81 0.33 0.01%
S&P 500 2,089.14 2.55 0.12%
market minute promo

company name or ticker
Company Photos
(Click to zoom)

Orexigen - Contrave Gains Market Share In Painfully Slow Race, While Sales Drop

Vivus- Qsymia Sales Will Likely Hit Problematic Point

New Strong Buy Stocks for November 23rd

Vivus - Can Equity Move On Flat Qsymia Sales?

Novo Nordisk: Is This Your Rainy Day Fund? I Think So!

Orexigen- Contrave Scripts Lead The Pack But Increasing Market Share Is Critical

Arena Conference Call Offers Honesty To Investors

3 Dangerous Stocks

While investing in stocks is a great way to build wealth, there are some that should be avoided at all costs.

Arena 3Q Loss Narrower-Than-Expected, Belviq in Focus

Wall Street Breakfast: AB InBev, SABMiller Seal MegaBrew Deal

See More Articles...